Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Douglas Smith

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1971
An empirical study of religious mysticismB Douglas-Smith
Journal of the National Cancer Institute|March 23, 2011
Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effectsB Douglas Smith
The American Journal of Medicine|June 28, 2012
Myelodysplastic syndromes: challenges to improving patient and caregiver satisfactionB Douglas Smith
Clinical Therapeutics|August 6, 2010
Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinibBrady Stein, B Douglas Smith
Stem Cell Reviews and Reports|October 13, 2016
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling PathwaysOhad Oren, B Douglas Smith
Clinical Therapeutics|February 3, 2019
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid LeukemiaJonathan Webster, B Douglas Smith
Leukemia Research|February 24, 2006
Developmental clinical trials: building one step at a timeJudith E Karp, B Douglas Smith
Current Hematologic Malignancy Reports|April 19, 2013
Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?Arati V Rao, B Douglas Smith
Leukemia Research|August 19, 2003
Ribonucleotide reductase: an old target with new potentialB Douglas Smith, Judith E Karp
Leukemia Research|May 3, 2005
Trying to improve clinical outcome in AML: lessons from negative trialsJudith E Karp, B Douglas Smith
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1971
An empirical study of religious mysticismB Douglas-Smith
Journal of the National Cancer Institute|March 23, 2011
Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effectsB Douglas Smith
The American Journal of Medicine|June 28, 2012
Myelodysplastic syndromes: challenges to improving patient and caregiver satisfactionB Douglas Smith
Clinical Therapeutics|August 6, 2010
Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinibBrady Stein, B Douglas Smith
Stem Cell Reviews and Reports|October 13, 2016
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling PathwaysOhad Oren, B Douglas Smith
Clinical Therapeutics|February 3, 2019
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid LeukemiaJonathan Webster, B Douglas Smith
Leukemia Research|February 24, 2006
Developmental clinical trials: building one step at a timeJudith E Karp, B Douglas Smith
Current Hematologic Malignancy Reports|April 19, 2013
Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?Arati V Rao, B Douglas Smith
Leukemia Research|August 19, 2003
Ribonucleotide reductase: an old target with new potentialB Douglas Smith, Judith E Karp
Leukemia Research|May 3, 2005
Trying to improve clinical outcome in AML: lessons from negative trialsJudith E Karp, B Douglas Smith
Pageof 21